Advancing Care for HR+/HER2- Breast Cancer - 2022 Oncology Fall

Advancing Care for HR+/HER2- Breast Cancer

Share

Program Content

Activities

  • Advancing Care for HR+/HER2- Breast Cancer: Managing Patients With CDK4/6 Inhibitors
    Advancing Care for HR+/HER2- Breast Cancer: Managing Patients With CDK4/6 Inhibitors
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 13, 2022

    Expires: October 12, 2023

    View Activity
  • SDM in Newly Diagnosed MBC
    Choosing a CDK4/6 Inhibitor in the Frontline Setting for HR+/HER2- Metastatic Breast Cancer: Highlighting the Importance of Shared Decision-Making
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2022

    Expires: December 11, 2023

    View Activity
  • Advancing Care for HR+/HER2- Breast Cancer
    Advancing Care for HR+/HER2- Breast Cancer: Managing Patients With CDK4/6 Inhibitors
    PCE On Demand Live Presentation
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 30, 2022

    Expires: December 29, 2023

    View Activity

Faculty

cover img faculity

Jeremy M. Force, DO

Assistant Professor
Department of Medicine
Division of Medical Oncology
Breast Oncology Program
Duke University
Durham, North Carolina

cover img faculity

Kathleen Madden, MSN, ANP-BC, AOCNP

Melanoma Program
NYU Langone Perlmutter Cancer Center
New York, NY

Provided by

ProCE Banner